Larson Financial Group’s Acer Therapeutics Inc ACER Stock Holding History

Larson Financial Group’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-922	Closed	-$751	–	1925
2023 Q3	$751	Hold	922	–	–	﹤0.01%	1533
2023 Q2	$851	Hold	922	–	–	﹤0.01%	1386
2023 Q1	$699	Hold	922	–	–	﹤0.01%	1384
2022 Q4	$2.31K	Hold	922	–	–	﹤0.01%	1169
2022 Q3	$1K	Hold	922	–	–	﹤0.01%	1273
2022 Q2	$1K	Hold	922	–	–	﹤0.01%	1171
2022 Q1	$3K	Hold	922	–	–	﹤0.01%	885
2021 Q4	$2K	Hold	922	–	–	﹤0.01%	984
2021 Q3	$2K	Hold	922	–	–	﹤0.01%	805
2021 Q2	$3K	Hold	922	–	–	﹤0.01%	712
2021 Q1	$3K	Hold	922	–	–	﹤0.01%	691
2020 Q4	$2K	Buy	+922	New	+$2.48K	﹤0.01%	662

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Larson Financial Group's ACER Position: Q4 2023 in Review

Larson Financial Group sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 922 shares — an estimated $751 sold.

Larson Financial Group first reported a position in ACER in Q4 2020 and held it in 12 quarters. The position peaked at $3K in Q1 2022. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Larson Financial Group reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Larson Financial Group sold 922 Acer Therapeutics Inc shares in Q4 2023, an estimated $751.
Larson Financial Group first reported a position in Acer Therapeutics Inc in Q4 2020 and held it in 12 quarters.
Larson Financial Group's Acer Therapeutics Inc position peaked at $3K in Q1 2022.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Larson Financial Group's 13F filing for Q4 2023, filed 1 Feb 2024.